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Abstract. Adult mouse brain contains at least two 
distinct spectrin subtypes, both consisting of 240-kD 
and 235-kD subunits. Brain spectrin(240/235) is 
found in neuronal axons, but not dendrites, when im- 
munohistochemistry is performed with antibody 
raised against brain spectrin isolated from enriched 
synaptic/axonal membranes. A second spectrin sub- 
type, brain spectrin(240/235E), is exclusively recog- 
nized by red blood cell spectrin antibody. Brain spec- 
trin(240/235E) is confined to neuronal cell bodies and 
dendrites, and some glial cells, but is not present in 
axons or presynaptic terminals. 
S 
INCE the discovery of nonerythroid spectrins (Goodman 
et al.,  1981; Glenney et al.,  1982; Bennett et al.,  1982; 
Repasky et al.,  1982; Burridge  et al.,  1982), the brain 
analogue has become the most completely described member 
of this family of proteins. Brain spectrin is a  1,000,000-mol- 
wt fibrous protein, with subunits of 240 kD (a) and 235 kD 
(t3) forming an  (a/3)2 tetrameric  complex.  The  a  subunit 
contains a binding site for calmodulin, while the phosphoryl- 
ated /3  subunit contains a  binding site  for brain  syndein/ 
ankyrin, a potential membrane attachment site. Brain protein 
4. l  and  f-actin attach to both  ends of the bivalent brain 
spectrin  tetramer  (for  reviews  see  Glenney and  Glenney, 
1983b; Goodman and Zagon, 1984; Bennett, 1985; Goodman 
and Zagon, 1986). Despite the rapid expansion of our knowl- 
edge concerning the structure and protein interactions of  brain 
spectrin  over the past four years, we do not as yet have an 
accurate picture of  the precise intracellular location ofspectrin 
within neural cells. This informational gap has been limiting 
our ability to ask appropriate questions concerning the poten- 
tial  functions of spectrin  within  nerve  cells.  Attempts  to 
localize spectrin  in mammalian nervous tissue by immunoh- 
istochemical analysis have yielded a  perplexing  set of facts, 
which on first glance appear contradictory. 
Levine and Willard prepared antibodies against an axonally 
transported protein with subunits of 240  kD and 235  kD, 
which they named fodrin (Levine and Willard,  1981). Fodrin 
was isolated by high salt extraction of guinea pig crude brain 
membranes  followed  by gel  filtration and  preparative  gel 
electrophoresis  (Levine and Willard, 1981), and the antibody 
raised  in rabbits cross-reacted  primarily with the 240-kD  a 
subunit of the 240-kD/235kD protein doublet (Cheney et al., 
1983). When indirect immunofluorescence studies were per- 
formed, fodrin antibodies stained the periphery of guinea pig 
neuronal cell bodies,  dendrites and axons in the peripheral 
nervous system, as well as staining the plasma membrane of 
Schwann cells (Levine and Willard,  1981). We now know that 
fodrin is a  member of the nonerythroid spectrin  family of 
molecules and refer to it as brain spectrin  (for review  see 
Goodman and Zagon,  1984). Our laboratory performed a 
systematic study of the distribution of spectrin in the central 
nervous system of mammals, using sagittal and coronal sec- 
tions of the mouse brain and an antibody against mouse red 
blood cell (rbc) ~  spectrin (Zagon et al., 1984). As our antibody 
stained both 240-kD  and 235-kD  polypeptides co-migrating 
with the brain spectrin  a and/3 subunits on immunoautora- 
diography of total mouse brain homogenate protein separated 
by SDS  PAGE, we expected  to see the intense staining of 
neuronal perikarya, dendrites, and axons described  in Wil- 
lard's elegant study (Levine and Willard,  1981). Instead, im- 
munofluorescent studies using monospecific mouse rbc spec- 
trin antibody consistently revealed  staining of all neuronal 
cell bodies and dendrites, but no staining of axons, synaptic 
structures,  or nuclei (Zagon et al.,  1984). After eliminating 
species differences, and differences between spectrin in central 
versus peripheral nervous system as the basis for these appar- 
ent contradictions in data (Goodman and Zagon, 1984), we 
were  faced  with  the  following  conundrum.  If antibodies 
against  mammalian brain  spectrin  and  rive spectrin  both 
specifically detect brain spectrin on immunoautoradiographic 
analysis  of total brain protein, then why do brain spectrin 
antibodies stain perikarya, dendrites, and axons, while  rbc 
spectrin  antibodies  stain  only perikarya and  dendrites on 
immunohistochemical analysis? 
1.  Abbreviations used in lhis paper." FCS, fetal calf serum; MAP, microtubule- 
associated protein; RBC, red blood cell; TBS, 50 mM Tris-HCl, pH 7.4, 150 
mM NaCI; TBSA, 5% BSA in TBS. 
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least two distinct spectrin subtypes both of which have sub- 
units of 240 and 235 kD. Brain spectrin(240/235) (nomencla- 
ture of Goodman and Zagon,  1984) is located in neuronal 
axons and, to a lesser extent, cell bodies. This brain spectrin 
subtype cannot be detected with rbc spectrin antibodies. Brain 
spectrin(240/235E) (E stands for erythrocyte subtype) is found 
in neuronal cell bodies and dendrites, but not in axons. This 
brain spectrin subtype is recognized specifically by an anti- 
body directed against rbe spectrin. These studies reconcile all 
previous observations on the location of spectrin  in  mam- 
malian brain, and suggest that a new level of sophistication 
in our approaches to mammalian brain spectrin function is 
appropriate. Two subtypes of spectrin have previously been 
described  in  avian  brain,  chicken  brain  spectrin(240/235), 
and brain spectrin (240/230) (Lazarides and Nelson,  1983a, 
b). Similarities and differences between the avian and mam- 
malian brain spectrin subtypes are discussed. 
Materials and Methods 
Isolation of  Spectrins 
Forty mice were anesthetized with ether, and after transcardiac  perfusion with 
phosphate-buffered saline (PBS), pH 7.4, with I% sodium citrate, the perfused 
blood  was collected and kept on ice. Brains were removed  and immediately 
frozen in liquid nitrogen. Starting with blood perfusate of 40 mice, rbc ghosts 
were prepared as described for human rbe ghosts (Goodman et at., 1982b) and 
rbe spectrin was purified by the method of Goodman et at. (1982a). 
Brain Spectrin Isolation.  Brain spectrin(240/235)  was isolated from the P2B 
fraction of mouse brain homogenates prepared with only minor modifications 
of the procedure of Gray and Whittaker (1962). 15 g frozen mouse brain tissue 
was homogenized  in  100 ml 0.32 M sucrose,  I mM EDTA,  10 mM Na2PO4, 
pH 7.0, 400 #M diisopropylfluorophosphate.  The homogenate was centrifuged 
at 900 g (5 min, 2"C)+ and the supernatant sedimented  at 39,000 g (20 min, 
2"C). The  crude  synaptosomes  were  resuspended  in  wash  buffer  (10  mM 
Na2PO+, pH 7.0, 1 mM EGTA, 400 ~M diisopropylfluorophosphate)  to a final 
volume of 40 ml and loaded onto four 28-ml sucrose step gradients of 1.2 and 
0.8 M sucrose in the same buffer. Gradients were centrifuged at  106,000 g (65 
min, 2"C). The P2B fraction from the 0.8/1.2  M sucrose interphase was washed 
in 3 vol of wash buffer and centrifuged at 39,000 g (20 min, 2"C). Extraction 
ofspectrin from the P2B fraction was performed by a modification of  previously 
described procedures (Bennett et al., 1982; Goodman et al., 1983). The pellet 
was resuspended in 100 ml ice cold low ionic strength buffer (0.1 mM EGTA, 
0.25  mM  dithiothreitol,  200  #M  diisopropylfluorophosphate,  pH  7.0) and 
centrifuged at 39,000 g (20 min, 2"C). Crude spectrin was extracted from the 
pellet by an incubation  with  100  ml low ionic  strength  buffer at 37°C. The 
suspension was centrifuged at 200,000 g (30 min, 2*(2). Proteins were precipi- 
tated by adding 0.35 g ammonium sulfate/ml  supernatant at pH 7.0, and kept 
on ice overnight. After a 15,000 g centrifugation (20 rain, 2"C), the ammonium 
sulfate precipitate was dissolved in 3 ml glycine-urea  buffer (25 mM glycine, 1 
mM EGTA,  1 mM NAN3, 0.25 dithiothreitol,  I M urea, pH 8.0) and dialyzed 
for 4 h at 4°C against the same buffer. The extract was centrifuged at 200,000 
g (3 h, 2"C). The supernatant was overlayed onto 5-18% linear sucrose gradients 
in  glycine-urea  buffer.  The larger spectrin  complexes  were  separated  from 
smaller proteins by rate zonal sedimentation  at 286,000 g (18 h, 2"C). Fifteen 
0.8-ml fractions were collected from the bottom of the tubes. Fractions  5-10 
were loaded onto a 70-ml Sepharose 4B column, equilibrated with PBS. Pure 
brain  spectrin(240/235)  was eluted immediately  after the void volume of the 
column. 
Immunological Methods 
Antibody Production. Native homogeneous mouse brain spectrin(240/235) and 
rbe  spectrin  were  used  as immunogens for raising antibodies  in  rabbits  as 
described (Goodman et al., 1981). The rbe spe~rin antibody  was previously 
characterized (Goodman et al., 1984b; Zagon et at., 1984). For the quantitative 
characterization  of the antisera the immunodot assay of Hawkes et al. (1982) 
and Jahn et al. (1984) were modified. Protein  solutions (0.5 #1) were spotted 
onto nitrocellulose paper with preprinted 3 × 3-ram grids (Millipore/Continen- 
tal Water Systems, Bedford, MA). The dried filters were washed with 50 mM 
Tris-HCI, pH 7.4, 150  mM NaCI (TBS) and blocked for  1 h in 5% bovine 
serum albumin in TBS (TBSA). The filters were incubated  overnight  with 
antiserum diluted 1:500 in TBSA and 0.1% Triton X- 100. The dots were rinsed 
four times (5 min) with TBSA and blocked for 30 min with TBSA. The filters 
were incubated  for 2 h with  ~2SI-protein A (0.1 uCi/ml) in TBSA and 0.1% 
Triton X-100, washed four times (5 min) with TBS and 0.1% Triton  X-100, 
and four times (20 min) with TBS. The wet filters were cut along the grids and 
assayed for radioactivity in a Packard 500 gamma counter. Each determination 
was performed  in triplicate.  All  steps were done at  room temperature.  The 
same procedure was also used for staining certain immunoblots,  and autora- 
diography of  the dry immunoblots  was performed using Kodak X-Omat XAR5 
film exposed at -20"C. 
Antisera Specificity. 8 mg brain  spectrin(240/235)  and 3 mg rbc spectrin 
were  coupled  to  1 g  CNBr-activated  Sepharose  4B  by  the  manufacturer's 
recommended  procedure  (Pharmacia  Fine Chemicals,  Piscataway, N  J). The 
coupling efficiency tested by the dot assay was >90%. The spectrin-Sepharose 
4B columns were pretreated  with 2 M MgCI2 in PBS and washed with PBS. 
The antisera against rbc and brain spectrin(240/235)  were passed through the 
brain  and  rbe  spectrin-Sepharose  4B  column,  respectively.  The  recovery, 
specificity, and cross-reactivity of the cleaned antisera was tested by the quan- 
titative dot assay and immunoblots.  The spectrin-Sepharose  4B columns were 
restored by 2 M MgC12 and PBS wash cycles. The antisera were passed through 
the columns at least three times. The IgG content  of the sera was determined 
by  a  quantitative  dot  assay  using  defined  amounts of rabbit  lgG  (Sigma 
Chemical  Co.,  St.  Louis,  MO) as  standards.  To  test  the  specificity of the 
antisera, proteins were transferred from polyacrylamide SDS slab gels to nitro- 
cellulose filter (  Millipore/Continental  Water Systems) by the method of  Towbin 
et al. (1979). The transfer buffer contained additional 0.005% SDS. A satisfying 
transfer was achieved after 6 h at 7 V/cm at 4"C. The proteins  on the filter 
were either stained with Amido black or antiserum. For immunological staining 
of the gel blots the procedure  for the dot  assay of Hawkes et al. (1982) was 
adapted and modified. Blots were washed with TBS for 5 min, blocked for 15 
min with  10%  normal  horse  serum in  TBS, and  incubated  overnight  with 
antisera diluted 1:1,000 in the blocking solution with 0.1% Triton X- 100. After 
four wash cycles  with TBS, the filters were incubated briefly in blocking solution 
alone, and 3 h in blocking solution together with 0.1% horseradish peroxidase- 
conjugated goat anti-rabbit  immunoglobulins  (Cappel Laboratories, Cochran- 
ville, PA) and 0.1% Triton X- 100. The blots were washed by four cycles with 
TBS. The peroxidase reaction  was developed  in 0.06% 4-chloro-l-naphthol, 
0.01% hydrogen peroxide in TBS for 15 rain. The filters were washed and air 
dried. 
Immunohistochemistry 
Freshly perfused mouse brains were frozen with freon. The 10-um thick cryostat 
sections were treated with 95% ethanol (30 min) and acetone (20 min) at 4"C. 
The sections on coverslips were washed with TBS for 5 min at room temperature 
and blocked with 3% fetal calf serum (FCS) in TBS for 15 min. The sections 
were incubated overnight with antiserum diluted  1:100 in 1% FCS in TBS with 
0.1% Triton  X-100. Unbound antibodies were washed away with four washes 
of 1% FCS, 0.1% Triton  X-100 in TBS and the sections were blocked again 
with 3%  FCS in TBS for  15  min,  followed by a  3-h incubation  with 0.3% 
horseradish  peroxidase-conjugated  goat  anti-rabbit  IgG  in  1%  FCS,  0.1% 
Triton  X-100 in TBS. Excess peroxidase was washed away with four changes 
of TBS over 30 min, and the remaining  peroxidase activity was stained with 
0.06% 4-ehloro-l-naphthol,  0.01% hydrogen peroxide in TBS for 15 rain. The 
sections were washed with TBS and mounted onto slides with 9:1  glycerol/ 
TBS. 
Electrophoresis 
SDS PAGE. Protein samples were separated on 5-15%  acrylamide SDS slab 
gels (Laemmli,  1970). Gels were stained with 0.025% Coomassie Brilliant Blue 
R  in  25%  isopropanol,  10%  acetic acid  overnight,  and destained  with  10% 
isopropanol,  10% acetic acid. 
Results 
Spectrin Isolation from Synaptic Membranes 
Rather than isolating spectrin from crude brain homogenates 
(Levine and Willard,  1981; Glenney et al.,  1982; Burridge et 
al.,  1982; Bennett et at., 1982; Goodman et at.,  1983, 1984b), 
we first prepared a synaptic/axonal membrane fraction by the 
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fraction of mouse brain homogenate was further fractionated 
on a  sucrose step gradient,  and the  material  collected from 
the  0.8-1.2  M  sucrose  interphase  (referred  to  as  the  P2B 
fraction by Gray and Whittaker,  1962),  was used for subse- 
quent  spectrin  isolations.  The  P2B  fraction  has  previously 
been demonstrated to be enriched in synaptic vesicles, axon 
segments  and,  to  a  lesser  extent  mitochondria  (Gray  and 
Whittaker,  1962);  we will  refer to it simply as an  enriched 
synaptic and axonal membrane preparation. As demonstrated 
in  Fig.  1,  we have  isolated  brain  spectrin(240/235)  by low 
ionic strength extraction of the P2B fraction, followed by rate 
zonal sedimentation through a linear 5-18% sucrose gradient, 
and gel filtration chromatography on a Sepharose 4B column. 
Highly purified brain spectrin(240/235) was eluted from the 
column immediately after the void volume. The yield of  brain 
spectrin(240/235)  from the P2B fraction was 0.22  mg brain 
spectrin/g  mouse  brain  tissue,  a  value  which  is  four-  to 
eightfold greater  than  previous  isolations  from  crude  brain 
homogenates.  In  addition  to  the  higher  yield  of spectrin 
isolated from the P2B fraction, we reasoned that ifa synaptic/ 
axonal form  of spectrin  existed  in  mammalian  neurons we 
would  be  enriching  this  spectrin  subtype  of beginning  the 
preparation  with  the  P2B  fraction  rather  than  total  brain 
protein. 
Characterization  of  Antisera 
Antiserum raised in rabbits against native mouse brain spec- 
trin(240/235) and mouse rbc spectrin were tested for affinity 
and  specificity by a  quantitative  immunodot assay (Fig. 2). 
The  antiserum  against  mouse  brain  spectrin(240/235)  was 
capable of  detecting purified brain spectrin(240/235) down to 
-1.5 ng, but also cross-reacted with purified mouse rbc spec- 
trin with a sensitivity to 5 ng (Fig. 2A). We wanted to have a 
probe which would strongly detect brain  spectrin(240/235), 
but would not be  very sensitive  to any rbc-related  spectrin 
subtype, if such a  subtype existed in mammalian brain.  We 
therefore  passed  the  brain  spectrin(240/235)  antiserum 
through  an  rbc  spectrin-Sepharose  4B  affinity  column  six 
times in an attempt to remove antibody capable of detecting 
rbc spectrin or rbc spectrin subtypes in brain.  As shown in 
Fig.  2B,  this  approach was successful as the depleted  anti- 
serum  against  brain  spectrin(240/235)  was still  sensitive  to 
1.5 ng of purified brain spectrin(240/235),  but showed little 
cross-reactivity with rbc spectrin (detection to -50 ng). The 
antiserum  against  mouse rbc spectrin  which has previously 
been described (Zagon et al.,  1984),  is extremely sensitive in 
detecting mouse rbc spectrin to 0.5  ng (Fig. 2C).  This anti- 
body showed  very little  cross-reactivity with  purified  brain 
spectrin(240/235) before or after (sensitivity to ~50 ng) three 
passages  through  a  brain  spectrin(240/235)-Sepharose  4B 
affinity column (Fig. 2 D). 
To demonstrate the specificity of the two antiserum before 
and after affinity chromatography, Western blot analysis was 
performed on mouse rbc membrane protein, purified mouse 
rbc spectrin,  mouse brain homogenate protein, and purified 
brain  spectrin(240/235)  (Fig.  3).  Although  the  antiserum 
against mouse brain spectrin stained the brain  spectrin 240- 
kD a subunit, as well as the 240- and 220-kD ~ and/3 subunits 
of mouse rbc spectrin prior to affinity chromatography, after 
several passages through the rbc spectrin affinity column this 
antiserum recognized only the 240-kD subunit of brain spec- 
trin(240/235)  in  total  brain  homogenates or purified  brain 
spectrin(240/235) (Fig. 3, C and D). Therefore, through the 
use  of the  affinity  chromatography depletion  step,  we  had 
obtained  an  antibody  which  would  recognize  brain  spec- 
trin(240/235), but would not detect mouse rbc spectrin (Fig. 
3D).  The  antiserum  directed  against  mouse  rbc  spectrin 
stained both the a  and/3 subunits of mouse rbc spectrin (Fig. 
3, E and F). Before and after affinity chromatography through 
Figure 1.  Brain spectrin(240/235) 
isolation. Coomassie Blue staining 
of proteins  separated  on  5-15% 
polyacrylamide  slab gels. Lane  1, 
mouse rbc ghost; lane 2, brain ho- 
mogenate; lane 3, P2B membrane 
fraction; lane 4, low ionic strength 
buffer extract.  (Lanes 5-11)  Odd 
numbered  fractions  from  rate 
zonal sedimentation  through  a 5- 
18%  sucrose  gradient  are  pre- 
sented. Lane 5 represents the bot- 
tom  of  the  gradient.  Fractions 
shown in lanes  7-9  were further 
purified  on  a  Sepharose  4B  col- 
umn. (Lane  12-19) Selected frac- 
tions from the Sepharose 4B col- 
umn  are  presented.  Lanes  repre- 
sent  the  following  column  frac- 
tions:  (12)  VJVo  =  1.15; (13) 
Ve/Vo =  1.36; (14) Ve/Vo =  1.56; 
(15) VJVo  =  1.97; (16) V¢/Vo = 
2.18; (17) Ve/Vo =  2.38; (18) Ve/ 
Vo = 2.58; (19) Ve/Vo = 2.99. Frac- 
tions collected from the Sepharose 
4B column were 1.7 ml, and Vo = 
25 ml. 
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Figure  2.  Quantitative  dot  assay 
with  antisera  against  brain  spec- 
trin(240/235)  (A  and  B)  and  rbc 
spectrin  (C and  D).  The  antisera 
were tested before passing through 
the affinity column (A and C) and 
after  six  cycles  through  the  rbc 
spectrin-Sepharose  4B  (B)  and 
three  cycles  through  the  brain 
spectrin(240/235)-Sepharose  4B 
(D) column, respectively. The im- 
munoreaction  of the  antisera  to 
defined amounts  (ng  per dot)  of 
brain  spectrin  (D)  or rbc spectrin 
(O)  is  expressed  in  cpm.  Preim- 
mune  serum  gave  background 
binding below 200 cpm. The anti- 
sera were diluted 1:500 (20 ug IgG/ 
ml). 
Figure 3. Specificity of the antisera. Protein samples were separated on 5-15% polyacrylamide slab gels and stained with Coomassie Blue (A) 
or transferred to nitrocellulose. Blots were stained with Amido black (B) or peroxidase immunostained with antiserum against brain spectrin(240/ 
235) before (C) and after (D) passing through the rbc spectrin-Sepharose 4B column, and antisera against rbc spectrin before (E) and after (F) 
passing through  the brain  spectrin(240/235)-Sepharose  4B column.  Non-immune serum  showed no immunostaining of proteins.  Lane  1, 
mouse rbc ghost; lane 2, pure rbc spectrin; lanes 3 and 4, brain homogenates of two different animals; lanes 5, pure brain spectrin(240/235) 
from synaptic/axonal membranes. Antisera were diluted 1:1,000 (10 ug IgG/ml). 
the brain  spectrin(240/235)  affinity column, this antiserum 
did not detect purified brain spectrin(240/235)  isolated from 
the P2B fraction, but stained a  240-  and 235-kD doublet in 
total brain homogenate (Fig.  3, E  and F).  This result which 
can  be  seen  more clearly in  Fig.  4C,  suggested that mouse 
brain  contains a  240/235-kD  form of brain  spectrin  which 
can be detected by anti-mouse rbc spectrin antibody, and is 
distinct from brain spectrin(240/235)  which is isolated from 
enriched  synaptic/axonal  membranes and  not  detected  by 
this antiserum. 
To rule out the possibility that this second form of brain 
spectrin was the result of residual blood in the brain prepa- 
rations, tissues from well perfused and nonperfused mice were 
compared (Fig. 4).  In Fig.  4, we demonstrate that the brain 
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15 % gradient polyacrylamide gels were stained with Amido black (A) 
or immunostained with specific antiserum against brain spectrin(240/ 
235) (B) or rbc spectrin (C) at 1:1,000 serum dilution  ( 10 ug lgG/ml) 
and a peroxidase-labeled  second antibody. Protein samples were rbc 
ghost  (lane  1), pure  rbc spectrin  (lane  2), total  brain  homogenate 
(lanes  3 and 6),  forebrain  homogenate (lanes  4 and  7), cerebellum 
homogenate (lanes 5 and 8), and pure brain spectrin  from synaptic/ 
axonal membranes (lane  9). Samples 3-5 were from a nonperfused 
mouse and samples 6-8 came from an extensively perfused  mouse. 
Only the relevant  portion of the blots are presented. 
spectrin(240/235)  antiserum reacts strongly with the 240-kD 
a  subunit of brain spectrin(240/235)  in total brain, forebrain, 
or cerebellar homogenates of perfused and nonperfused mice 
(Fig. 4 B). This brain spectrin(240/235)  antiserum specifically 
stains the a  subunit of purified brain spectrin(240/235).  The 
mouse rbc spectrin antiserum stains both the a and ~ subunits 
of mouse rbc spectrin, but does not detect brain spectrin(240/ 
235) isolated from enriched synaptic/axonal membranes (Fig. 
4 C,  lane  9).  In  nonperfused  mouse  brain,  the  rbc  spectrin 
antiserum strongly detected the 240-kD and 235-kD subunits, 
as well as a 220-kD subunit that co-migrated with the mouse 
rbe spectrin/~ subunit (Fig. 4 C, lanes 3-5).  In perfused mice 
the staining of the 240/235kD  doublet in total brain homog- 
enates, forebrain, and cerebellum was still evident, with pref- 
erential staining of the 235-kD subunit (Fig. 4 C, lanes 6-8). 
The lack of staining  of the  220-kD subunit  and  diminished 
staining  of the 240-kD  subunits  in perfused brain  indicated 
that these immunoreactive bands were due  to rbc contami- 
nation  (compare  Fig.  4C,  lanes 3-5  vs. 6-8),  while  the  re- 
maining weak staining of the 240-kD band and the unaltered 
strong  staining  of the  235-kD  subunit  was  due  to  an  rbc- 
related subtype of brain spectrin. We refer to this subtype as 
brain  spectrin(240/235E)  (the  E  represents  erythrocyte-re- 
lated) in order to distinguish  it from the brain spectrin(240/ 
235).  Similar results were  obtained  when  antigens  were  de- 
tected within the polyacrylamide gel by the gel overlay method 
and  immunoautoradiography  (Kay  et  al.,  1983)  (data  not 
shown). 
Different Distribution of Brain Spectrin(240/23 5) and 
Brain Spectrin(2 40  / 2 3 5  E) in Adult Mouse Brain 
Final proof that the brain spectrin(240/235)  and brain spec- 
trin(240/235E)  proteins represented distinct  subtypes within 
mammalian brain, came from extensive immunohistochem- 
ical  studies  which  demonstrated  different  locales  of these 
subtypes within  neural cells (Figs.  5  and 6). Immunoperoxi- 
dase  studies  on  sagittal  cryostat  sections  stained  first  with 
antiserum against rbc spectrin (which  specifically recognizes 
brain  spectrin[240/235E])  or  antiserum  against  brain  spec- 
trin(240/235)  showed a strikingly different subcellular distri- 
bution of subtypes. In the cerebellum, the brain spectrin(240/ 
235) antiserum exhibited staining of the medullary layer, the 
internal granule layer and molecular layer (Fig. 5 a). At higher 
magnification, the peroxidase staining was confined to axonal 
processes in the medullary layer (Fig. 5, c and h), basket fibers 
which  surround  Purkinje  cells (Fig.  5 d),  and  fibers (axons) 
coursing  through  the  internal  granule  layer  (Fig.  5e).  In 
addition,  only weak staining was observed in the cell bodies 
of granule cells; intense staining was often recorded between 
granule  cells  due  to  immunoreactivity  of  axons  coursing 
through the internal granule layer (Fig. 5g). Some deep cere- 
bellar  nuclei  neurons  (Fig.  5f)  demonstrated  "clusters"  of 
staining  reaction  associated  with  the  cell  surface;  this  may 
represent  staining  of synaptic  terminals.  Faint  staining  of 
Purkinje  cell bodies was often observed.  Other  areas of the 
brain expressed an intense axonal staining as exemplified by 
the  brain  stem,  corpus  callosum  (Fig.  5,i  and j),  or  optic 
chiasma (not shown). Nuclear, dendritic,  or glial staining was 
not detected with antiserum against brain spectrin(240/235). 
The rbc spectrin antibody revealed a totally different distri- 
bution of brain spectrin(240/235E).  The cerebellum overview 
(Fig. 6 a) exhibited an intense staining of the internal granule 
layer, a  moderate  staining  of the  molecular  layer, but  little 
staining of the medullary layer; a  few remaining erythrocytes 
could be recorded in the cerebellum (Fig. 6 c). The subcellular 
localization  of staining  was confined  to the cell  bodies and 
dendrites of neurons,  such as the deep cerebellar nuclei  neu- 
rons (Fig. 6 d), Purkinje cells (Fig. 6f), and granule cells (Fig. 
6g). Processes extending from the internal granule layer into 
the molecular layer were observed, and may represent staining 
of Bergmann glial fibers (Fig.  6 e).  Neuronal  cell bodies and 
dendrites  were  prominently  stained  in  other  brain  regions 
(Fig.  6, j  and k), and  cells suggestive of glial cells (Fig.  6,  h 
and  i)  were  observed to be  immunoreactive.  There  was no 
detectable  brain  spectrin(240/235E)  in  axons.  Therefore, 
brain spectrin(240/235)  and brain spectrin(240/235E)  can be 
distinguished  by their  differential  staining  by rbc and  brain 
spectrin antiserum on Western blots, and distinct localization 
within neural tissue. 
Figure 5. Distribution  of the brain spectrin(240/235)  in adult mouse brain.  Cryostat sections (10 um) were stained  with brain spectrin(240/ 
235) antiserum (after  affinity  chromatography) followed by peroxidase-conjugated  goat anti-rabbit IgG. (a)  Low magnification  view of the 
cerebellar cortex.  Staining of the medullary layer (MED), the molecular layer (MOL) and internal granule layer (IGL) are demonstrated. PIA, 
pia. (b) An area similar to that in a stained with preimmune serum. (c) High magnification  photomicrograph of the MED demonstrates staining 
of axons (arrows). (d) Basket fibers (bf) stained  in the MOL. (e) Staining  of axonal fibers (arrow) coursing through the IGL, with relatively 
weak staining  of granule cells. (f) Staining of a neuronal cell body in the deep cerebellar nuclei, with clusters of stain (arrows) associated with 
the cell surface. (g) High magnification  photomicrograph of granule cells (gc) demonstrates weak cell body staining,  with intense  staining  of 
The Journal of Cell Biology,  Volume 102, 1986  2092 axons cut in cross-section (arrows) which lie between the granule cells. (h-j) Axonal (arrows) staining in the cerebellar MED (h), brain stem (/), 
and corpus callosum in cross-section (j). Antiserum dilution was  1:100 (100 ug IgG/ml). Bars, (a and b) 50 urn; (c-f and j) 12.5 t~m; and (g 
and h) 5 urn. 
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ron.  The  double  dots  represent  brain  spectrin(240/235),  most  of 
which is found in axons with less in the cell body. The dashes are the 
brain spectrin(240/235E)  subtype which is localized in the cell body 
and dendrites. 
Discussion 
Characterization of Brain Spectrin(2401235)  and 
Brain Spectrin(2 40/  2 3 5  E) 
As summarized in Fig. 7, this report demonstrates that mam- 
malian brain contains at least two spectrin subtypes. (a) Brain 
spectrin(240/235) is enriched in the axons of neurons and to 
a lesser extent in the cell bodies, but is not found in dendrites. 
Brain spectrin(240/235)  is detected with antiserum  directed 
against spectrin isolated from a crude synaptic/axonal mem- 
brane  preparation  (P2B  fraction),  but  is  not  detected  with 
antiserum against rbc spectrin. (b) Brain spectrin(240/235E) 
is  present  in  neuronal  cell  bodies  and  dendrites,  but  is  ex- 
cluded from axons. This subtype of brain spectrin is detected 
specifically by antiserum against mouse rbc spectrin. Unlike 
the brain  spectrin(240/235)  subtype,  rbe spectrin antiserum 
also recognizes an  immunoreactive  analogue of spectrin  in 
certain  glial  cell  types.  This  analogue  may  be  similar  or 
identical to brain spectrin(240/235E).  While we demonstrate 
here for the first time that mammalian brain contains at least 
two distinct  spectrin subtypes, we want to clearly state that 
additional  subtypes may well be present.  We do not as yet 
know whether these brain spectrin subtypes represent distinct 
gene  products  or  different  posttranslational  modifications. 
Evidence  for the  presence  of multiple  spectrin  isoforms in 
mammalian skeletal muscle has recently appeared in abstract 
form (Shile et al.,  1985). 
The results presented here suggest a reasonable explanation 
for the  previous conundrum  concerning the  localization  of 
spectrin within mammalian brain. As brain spectrin(240/235) 
and brain spectrin(240/235E) are both partially eluted by high 
and low ionic strength extraction of crude brain homogenates 
(which has been the standard protocol in this field for brain 
spectrin isolation), the antibodies which have been previously 
obtained against mammalian brain  spectrin probably recog- 
nize both  subtypes.  When  staining the  neuronal  cell  body, 
dendrites, and axons of guinea pig peripheral  nervous tissue 
(as  well  as  when  staining  Schwann  cells)  with  antibodies 
against guinea pig fodrin (brain spectrin), Levine and Willard 
were  most  likely  detecting  both  brain  spectrin  subtypes, 
whereas  Zagon  et  at.  (1984),  using  the  same  mouse  rbc 
spectrin antibody used in this report, were specifically detect- 
ing the brain spectrin(240/235E) subtype. 
Comparison of  Mammalian and Avian Brain 
Spectrin Subtypes 
Lazarides and Nelson (1983a,  b) have described two forms 
of chicken brain spectrin: (a) brain spectrin(240/235),  which 
they  detected  in  the  cell  bodies,  axons,  and  dendrites  of 
neurons at all stages of cerebellar development with an anti- 
body against chicken rbc spectrin 240-kD a  subunit; and (b) 
brain spectrin(240/230 or 240/220), a subtype which is anti- 
genically  and  structurally  nearly  identical  to  chicken  rbc 
spectrin,  and  which  is  located  exclusively  on  the  plasma 
membrane of the neuronal cell body and dendrites accumu- 
lating at the phase of synaptogenesis (Lazarides and Nelson, 
1983a,  b).  The chicken brain spectrin(240/230  or 240/220) 
which is detected by Lazarides and Nelson with an antibody 
against the B subunit of chicken rbc spectrin, appears to have 
the same location within neurons as does mammalian brain 
spectrin(240/235E),  but contains a  230-kD B' or 220-kD/~ 
subunit. The location of chicken brain spectrin(240/235) was 
in neuronal cell bodies, dendrites,  and axons of the cerebel- 
lum;  this  localization  differs  from  mammalian  brain  spec- 
trin(240/235)  which  is  enriched  in  axons,  present  in  low 
quantity  in  cell  bodies,  and  not  present  in  dendrites.  One 
should keep in mind however that the c~ subunit of  all chicken 
spectrins is an antigenically and structurally constant subunit 
(Glenney and Glenney,  1983a, b; 1984).  Therefore, by using 
an  antibody against the  a  subunit  of chicken  rbc  spectrin, 
Lazarides and Nelson would have been detecting all chicken 
brain  spectrin  subtypes in cerebellum,  not only brain  spec- 
trin(240/235)  as  suggested (Lazarides  and  Nelson,  1983a). 
Despite this caveat, it would appear that there may be differ- 
ences  in  the  location  of spectrin(240/235)  subtypes  when 
avian and mammalian brain are compared. 
Figure 6. Distribution  of brain spectrin(240/235E)  in adult mouse brain tissue. Cryostat sections (10 urn) were stained with mouse rbe spectrin 
antiserum  (after affinity chromatography)  followed by peroxidase-conjugated goat anti-rabbit IgG. (a) Low magnification photomicrograph  of 
the cerebellar cortex. Note the intense staining of the internal granule layer (IGL), moderate staining of the molecular layer (MOL), and little 
or no staining of the medullary layer (MED). The lack of staining of the MED is striking when compared to Fig. 5 a. (b) Same area as a stained 
with preimmune serum.  (c) A higher magnification  photomicrograph  of the cerebellum demonstrates  intense staining of individual  granule 
cells within the IGL, and an unstained  MED except for the red blood cells (rbc) (arrows). (d) The cell body and processes of a neuron within 
the deep cerebellar nuclei are stained. (e) The MOL demonstrates  only low to moderate staining. Immunoreactive fibers in the MOL (arrows) 
may be Bergmann  glia processes. 0  c) The cytoplasm  of Purkinje  cells (pc) are  stained. (g) Granule  cells show a characteristic  cytoplasmic 
staining pattern between the large cell nucleus and the plasma membrane (arrows). In the cortex of the forebrain, staining of neural cell bodies 
and processes (arrows) were recorded (h and i); the cell in h was tentatively identified as an oligodendrocyte, while the cell in i resembles an 
aslrocyte contacting a blood vessel (b). (j and k) Staining of neuronal  cell bodies and dendrites were observed independent  of whether frozen 
cryostat sections (see Materials and Methods) (j) or those fixed in 2% paraformaldehyde, 0.25% glutaraldehyde, PBS, pH 9.0 (50-urn vibratome 
sections) (k) of brain were used. Neurons in the region of the vestibular nucleus are shown in both j and k. Antiserum was diluted  1:100 (100 
#g IgG/ml).  Bars, (a and b) 50 urn; (c) 20 urn; (d-f, h-k) 12.5 vm; and (g) 5 #m. 
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Cellular Compartments 
We demonstrate here that brain spectrin(240/235) is primar- 
ily an axonal subtype, while brain spectrin(240/235E) is found 
in dendrites and perikarya. Similarly we have recently dem- 
onstrated that there are at least three forms of brain protein 
4. l: a  cell body/dendrite form (Goodman et al.,  1984 a), an 
axonal form, and a unique form in the presynaptic terminals 
(synapsin I) (for review see Krebs et al., 1986). This compart- 
mental separation of cytoskeletal subtypes or isoforms is not 
unique to spectrin and related proteins, a- and/~-tubulin are 
present in both mammalian neuronal and glial cell types, but 
while a- and/3-tubulin are both present in neuronal dendrites 
and glia, ~-tubulin is either diminished or modified in parallel 
fiber axons  and  in  myelinated axons  in  the  white  matter 
(Cumming et at.,  1982;  1984). The different a- and/3-tubulin 
isoforms may be of importance in the surface interaction of 
microtubules  with  other  structural  and  regulatory  cellular 
components (Sullivan  and  Wilson,  1984).  In  addition,  the 
microtubule-associated proteins (MAPs) MAP1, MAP2, and 
MAP3,  all  have  distinct  localization  within  mammalian 
neural cells. MAP1  is present in the cell body, in initial axon 
segments, and throughout the dendritic tree of Purkinje cells; 
it is less prominent in granule cells,  and not present in glial 
cell types (Huber and Matus, 1984; Bloom et al.,  1984,  1985), 
although  the  recognition  of MAP1  in  glial  cells  seems  to 
depend on the specific monoclonal antibody used. MAP2 is 
present only in dendrites beyond the initial proximal portion, 
and is not present in the cell bodies or axons of Purkinje cells 
or granule cells (Matus et al.,  1983; Huber and Matus, 1984). 
MAP2 was found at fivefold lower concentration relative to 
tubulin  in  microtubule preparations of white matter versus 
gray  (Vallee,  1982).  MAP3,  unlike  MAP1  and  MAP2,  is 
present in both neuronal and glial cells. In neurons, MAP3 is 
found exclusively in  neurofilament rich  axons (myelinated 
axons, basket fibers) (Huber et al.,  1985). The neurofilament 
proteins  of 73  kD  and  145  kD  are  present  in  axons,  cell 
bodies, and dendrites of mammalian neurons, while the 195- 
kD neurofilament protein is found primarily in axons (Hiro- 
kawa et al.,  1984). Actin appears to be concentrated in neu- 
ronal dendrites and postsynaptic densities and may be present 
in different isotypic forms (Matus et al.,  1982; Caceres et at., 
1983). From the studies cited above it is clear that the den- 
dritic, cell body, and axonal compartments of a neuron con- 
tain strikingly different cytoskeletal compositions. It is reason- 
able to believe that control of the expression of genes coding 
for these compartment-specific cytoskeletal subtypes (such as 
brain  spectrin[240/235]  and  brain  spectrin[240/235E]),  or 
isoforms of other cytoskeletal proteins, may be at the center 
of the microdifferentiation process, in which a  neuron must 
produce axonal or dendritic branches,  and presynaptic and 
postsynaptic terminals  in  regulated  sequence  and  number. 
Furthermore, the diversity in cytoskeletal proteins is undoubt- 
edly essential to unique functions of neuronal compartments 
such as translocation of organelles, axonal transport, synaptic 
transmission, and maintaining the architecture of cell bodies, 
dendrites, and axons. Brain spectrin(240/235) and brain spec- 
trin(240/235E)  may play essential roles in  establishing and 
maintaining these cytoskeletal microdomains within neuronal 
compartments. 
Prospectives  for Future Studies 
It will  be of interest to determine the  relative quantities of 
mammalian brain spectrin(240/235) and brain spectrin(240/ 
235E).  This quantitation will be possible only after the puri- 
fication of both brain spectrin subtypes is complete, for use 
in quantitative immunodot assays or radioimmunoassays. In 
addition,  before framing appropriate questions  concerning 
the  functions  of discrete  brain  spectrin  subtypes, we  must 
know the precise intracellular location and contacts of brain 
spectrin subtypes at the electron microscope level of resolu- 
tion. These studies which are reported in a  separate manu- 
script (Zagon et at.,  manuscript submitted for publication), 
confirm our immunohistochemical observations at the light 
microscope level.  In  addition  they clearly demonstrate the 
presence of brain  spectrin(240/235)  in  the  presynaptic ter- 
minals and brain spectrin(240/235E) in the postsynaptic ter- 
minals. Koenig and Repasky (1985) have recently demonstra- 
ted the presence of a spectrin at the synaptic junctions of the 
goldfish Mauthner neuron  using an antibody raised against 
the 240-kD a  subunit of chicken rbc spectrin. 
An  important  consequence  of this  report  is  that  future 
studies on the functional characteristics of mammalian brain 
spectrin  should  consider  the  necessity of isolating  distinct 
subtypes of brain spectrin.  Although  we have not yet been 
able to quantitate the relative amounts of spectrin(240/235) 
and spectrin(240/235E)  in mammalian brain, it is probably 
no longer sufficient to isolate total mammalian brain spectrin 
(which contains a  co-mixture of the  subtypes) and use this 
material to  study binding  to  syndein/ankyrin,  calmodulin, 
protein 4.1,  or actin. We do not know whether distinct brain 
spectrin subtypes will have different functional characteristics. 
A  more  sophisticated  approach  to  brain  spectrin  function 
may be necessary in future studies. 
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